Group One Trading’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,629
Closed -$27.4K 8157
2026
Q1
$30.3K Buy
1,629
+1,403
+621% +$26.5K ﹤0.01% 5665
2025
Q4
$3.32K Sell
226
-194
-46% -$3.1K ﹤0.01% 7355
2025
Q3
$7.44K Sell
420
-1,190
-74% -$24.7K ﹤0.01% 7348
2025
Q2
$37.8K Buy
1,610
+1,355
+531% +$33.4K ﹤0.01% 5801
2025
Q1
$7.04K Buy
255
+235
+1,175% +$9.02K ﹤0.01% 6478
2024
Q4
$1.05K Buy
+20
New +$1.25K ﹤0.01% 6876

Other funds holding MRNY

Group One Trading's MRNY Position: Q2 2026 in Review

Group One Trading sold out of YieldMax MRNA Option Income Strategy ETF (MRNY) in Q2 2026, closing a stake of 1,629 shares — an estimated $27.4K sold.

Group One Trading first reported a position in MRNY in Q4 2024 and held it in 6 quarters. The position peaked at $37.8K in Q2 2025. 10 funds tracked by Wall St. Rank hold MRNY as of Q2 2026.

  • Group One Trading reported no remaining YieldMax MRNA Option Income Strategy ETF position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 1,629 YieldMax MRNA Option Income Strategy ETF shares in Q2 2026, an estimated $27.4K.
  • Group One Trading first reported a position in YieldMax MRNA Option Income Strategy ETF in Q4 2024 and held it in 6 quarters.
  • Group One Trading's YieldMax MRNA Option Income Strategy ETF position peaked at $37.8K in Q2 2025.
  • 10 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.